Search Follow us

Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Director

Sean Conroy

Sean Conroy
Associate Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Director

Maxim Jacobs

Maxim Jacobs
Managing Partner, North America

Dr Susie Jana

Dr Susie Jana
Director

Alice Nettleton

Alice Nettleton
Associate Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Director

Dr John Savin

Dr John Savin
Analyst

Andy Smith

Andy Smith

Briana Warschun

Briana Warschun
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Associate Director

By region

Recent initiations

Shield Therapeutics ADL Bionatur Solutions
OSE Immunotherapeutics CASI Pharmaceuticals
Auris Medical Holding MGC Pharmaceuticals

Recent QuickViews

MedinCell

Long-acting injectable drug delivery vehicle

Pharmaceuticals & healthcare | published 20/12/2018
TruScreen

Fast and objective cervical cancer screening

Pharmaceuticals & healthcare | published 06/12/2018
Oxford Immunotec

Not your usual diagnostics company

Pharmaceuticals & healthcare | published 30/11/2018
Vectura

Not pausing for breath

Pharmaceuticals & healthcare | published 26/11/2018

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

ReNeuron Group

Exciting positive data in retinitis pigmentosa (RP)

Update | Pharmaceuticals & healthcare | 22/02/2019

ReNeuron’s announcement of early but exciting data on three patients in the clinical study of its human retinal progenitor cell (hRPC) product was…

Shield Therapeutics

Fortified for growth

Initiation | Pharmaceuticals & healthcare | 19/02/2019

Shield Therapeutics is focused on the development and commercialisation of Feraccru, a CHMP-approved oral formulation of iron positioned for the treatment…

Pixium Vision

Financials in line as Prima advances

Update | Pharmaceuticals & healthcare | 19/02/2019

Pixium reported FY18 financials and reiterated that it is on track to start a pivotal study in the EU for its Prima bionic vision system (BVS) in H219…

InMed Pharmaceuticals

Entering the clinic by the end of the year

Update | Pharmaceuticals & healthcare | 14/02/2019

InMed recently reported results for the second quarter of FY19 and is on track to bring INM-750 for epidermolysis bullosa (EB) into the clinic by the end…

Oncology Venture

Multiple programme updates

Update | Pharmaceuticals & healthcare | 13/02/2019

Oncology Venture (OV) continues to provide regular response data from its ongoing LiPlaCis Phase II trial in patients with metastatic breast cancer (mBC).…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceuticals & healthcare Show companies